Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole Plus Metronomic Capecitabine in Advanced Breast Cancer
NCT04942899Phase 2Unknown
- Sponsor
- Assiut University
- Start
- Aug 2023
- Primary completion
- Aug 2024
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
01
Overview
A Phase 2 trial of capecitabine in breast cancer, sponsored by Assiut University. Status: unknown.
02
Drugs
capecitabine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT04942899.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04942899.